Provides that purchase of insulin is not subject to deductible; requires health insurers to limit copayments and coinsurance for insulin; requires insulin manufacturers to submit report to Commissioner of Banking and Insurance.***
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2020
Committee Review
Floor Vote
Governor
Introduced Jan 14, 2020
Last action Jun 16, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
5
Key actions
2
Committee
4
Jun 16, 2021
Lower · Passed
Reported out of Assembly Committee with Amendments, 2nd Reading
lower
Mar 17, 2021
Committee
Recommitted to Assembly Appropriations Committee
lower
Feb 24, 2021
Lower · Passed
Reported out of Assembly Committee with Amendments, 2nd Reading
lower
Feb 13, 2020
Committee
Reported out of Senate Committee with Amendments and Referred to Assembly Appropriations Committee
lower
Jan 14, 2020
Introduced
Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee
lower
3 primary · 11 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Annette Quijano
DDemocratic
P
JA
John Armato
DDemocratic
P
Robert Karabinchak
DDemocratic
Co
Britnee Timberlake
DDemocratic
Co
DR
Daniel R. Benson
DDemocratic
Co
JD
Joann Downey
DDemocratic
Co
MM
Mila M. Jasey
DDemocratic
Co
Pam Lampitt
DDemocratic
Co
Roy Freiman
DDemocratic
Co
TP
Thomas P. Giblin
DDemocratic
Co
VV
Valerie Vainieri Huttle
DDemocratic
Co
Verlina Reynolds-Jackson
DDemocratic
Co
VM
Vincent Mazzeo
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about A 954
Scope: NJ
Hi! I can help you understand A 954. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline